Elekta AB (EKTAF.PK) on Monday said it has received clearance to CE mark its new multileaf collimator Agility, a beam-shaping device integrated into the head of a linear accelerator. Patients and clinics will benefit from the speed and reliability of this new MLC design, the company said.
Tomas Puusepp, President and CEO of Elekta, said, "According to WHO, cancer is a leading cause of death worldwide, and the incidence is expected to continue rising significantly. To meet this increasing need, we have collaborated closely with leading hospitals and research institutions to develop a solution that can increase the throughput of patients while delivering outstanding precision."
Agility has 160 tungsten leaves with a leaf speed of up to 6.5cm per second. The leaf speeds are twice as fast as other MLCs commonly used within the industry. This means shorter treatment time for patients.
The device has twice as many leaves as a standard MLC, which will enable clinicians to sculpt delivered radiation doses to the contours of tumors with great precision.
Clinicians can be confident that the leaves are producing the correct shape to deliver the prescribed treatment to the patient, the company said.
Agility's leafbank is designed for extraordinarily low transmission as reducing unwanted dose to healthy tissue or organs at risk is important.
Agility can be purchased as part of a new radiotherapy solution from Elekta, as well as an upgrade option to a large part of Elekta's installed base of linear accelerators.
by RTT Staff Writer
For comments and feedback: firstname.lastname@example.org